Design of a promising gene therapy method to treat Wilson's disease

(Universidad de Navarra) Spanish scientists at the University of Navarra have designed VTX801, a promising gene therapy method to treat Wilson's disease. They expected to begin the first clinical trials on patients in 2018. The Massachusetts Eye and Ear Infirmary, associated with Harvard University, has participated in its development. This Spanish research project has attracted leading international investors in biotechnology by forming Vivet Therapeutics, an emerging company which has raised € 37.5 million in its Series A financing round.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news